NCT01706432
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting

Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain, Liver, Lung
Additional Notes: Patients must have 1-5 metastatic sites
Exclusions: Patients with prior treatment for their metastatic disease within 3 years; Patients with prior radiotherapy that would result in overlap of radiation therapy fields
https://ClinicalTrials.gov/show/NCT01706432